Search Results
Slidesets
Minimising treatment duration and doses | Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Focus on psychosocial needs | Molly Perkins, PhD
Presented at:
International Workshop on HIV & Aging 2016
Slidesets
Switching ART in Suppressed Patients: When, How, and to What? | Monica Gandhi
Presented at:
European HIV Clinical Forum 2023
Abstracts
HIV Cascade of Care in Women Living with HIV In the Postpartum Period in Canada
N. Zanre
Reviews in Antiviral Therapy & Infectious Diseases 1, 2021
Presented at:
International Workshop on HIV & Women 2021
Slidesets
Risky Business Identifying and Mitigating MTCT Risks among Pregnant and... - Karen Webb
Presented at:
International Workshop on HIV & Adolescence 2021
Abstracts
Response to hepatitis B vaccination among HIV-exposed uninfected children in Canada
S. Dorval
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Slidesets
Update on Antiviral Agents for Patients with Limited Treatment Options: Clinical Trials and Real-World Data | Antonella Castagna
Presented at:
European HIV Clinical Forum 2023
Abstracts
Baseline gut-associated microbial signatures may help predict HIV-1 viral control after treatment interruption
A. Borgognone
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020